[ad_1] At three years, over 80% of patients with moderately to severely active UC who were in remission with mirikizumab sustained long-term remission and relief from disruptive symptoms, including bowel urgency Mirikizumab also helped over […]
Trending Stories
Uranium Royalty Acquires Current Royalty on Cameco’s Complex Level Millennium and Cree Extension Uranium Tasks
[ad_1] DESIGNATED NEWS RELEASE VANCOUVER, BC, Oct. 28, 2024 /PRNewswire/ – Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) (“URC” or the “Company“) is happy to announce that it obtained an present royalty at the Millennium […]
China confident in achieving around 5% GDP growth for 2024, will strengthen counter-cyclical fiscal policies, says vice Minister of Finance
[ad_1] BEIJING, Oct. 28, 2024 /PRNewswire/ — China is confident to achieve around 5-percent GDP growth target for 2024, and the country will step up counter-cyclical adjustments in fiscal policy in addition to monetary policy stimulus, […]
„Chancen in China” auf der Virtual Industry Expo
[ad_1] PEKING, 28. Oktober 2024 /PRNewswire/ — „Alternatives in China” (Chancen in China) auf der Digital Trade Expo bietet eine detaillierte Erkundung der dritten globalen Digital Trade Expo aus der Sicht eines Journalisten aus Kasachstan, […]
Buyback of Class B shares in Essity during week 43, 2024
[ad_1] STOCKHOLM, Oct. 28, 2024 /PRNewswire/ — Between October 21, 2024, and October 25, 2024, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program […]
